Physician profile
Megha Prasad
NPI 1174887137
$813,243.64
in general payments reported to CMS, 2019-2025
36 companies · $297K in 2025
The $297K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,581 · 2020: $1,252 · 2021: $36K · 2022: $22K · 2023: $143K · 2024: $310K · 2025: $297K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $343K · Consulting Fee: $297K · Travel and Lodging: $71K · Honoraria: $19K · Food and Beverage: $15K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,400 · Grant: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $343,362.81 |
| Consulting Fee | $297,157.50 |
| Travel and Lodging | $70,717.22 |
| Honoraria | $18,855.00 |
| Food and Beverage | $14,874.72 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,400.00 |
| Grant | $134.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $176,913.62 | 2019-2025 | Kengreal |
| Abbott Laboratories | $123,627.37 | 2021-2025 | Optis, Coroflow, Pressurewire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $118,703.98 | 2021-2025 | Jardiance |
| Medtronic, INC. | $110,451.79 | 2021-2025 | Ffrangio, Onyx Frontier, Symplicity G3 |
| Zoll Circulation INC | $66,231.77 | 2022-2025 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Shockwave Medical, INC | $55,286.91 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $49,051.12 | 2019-2025 | General - Vascular Access, Watchman Flx, Avvigo Guidance System |
| Lilly USA, LLC | $21,758.50 | 2023-2025 | Jardiance |
| Cathworks, INC. | $18,471.15 | 2023-2025 | Ffrangio |
| Terumo Medical Corporation | $13,234.41 | 2024-2025 | Glidewire, Metacross Otw, Angio-Seal |
| Abiomed | $13,014.15 | 2019-2025 | Impella |
| Biotronik INC. | $12,010.16 | 2022-2025 | Orsiro Mission, Pk Papyrus, Trapit |
| Neovasc Medical INC | $11,928.60 | 2022-2023 | |
| Spectrawave, INC | $9,843.50 | 2024-2025 | Starlight Imaging Catheter, Hypervue Imaging System |
| Astrazeneca Pharmaceuticals Lp | $3,541.29 | 2019-2024 | Lokelma |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $2,963.81 | 2021-2025 | Coronary Other |
| Ge Healthcare | $2,216.00 | 2024 | |
| Medtronic Vascular, INC. | $1,256.88 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $421.50 | 2019-2024 | |
| Cardiovascular Systems INC. | $396.47 | 2019-2021 | |
| Cardinal Health 200 LLC | $313.85 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $289.52 | 2021-2025 | Lifevest |
| Cardiva Medical, INC. | $277.96 | 2019 | |
| Asahi Intecc USA, INC. | $139.08 | 2023-2025 | Asahi Ptca Guide Wire, Asahi Peripheral Vascular Wires, Peripheral Vascular |
| Heartflow, INC. | $131.33 | 2019 | |
| Regeneron Pharmaceuticals, INC. | $129.72 | 2019 | |
| Amgen INC. | $126.15 | 2020-2023 | Repatha |
| Pfizer INC. | $125.38 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $112.95 | 2020 | |
| Teleflex LLC | $65.40 | 2023 | Turnpike |
| Takeda Pharmaceuticals U.S.A., INC. | $54.71 | 2020 | |
| Angiodynamics, INC. | $46.98 | 2019 | |
| Janssen Pharmaceuticals, INC | $40.36 | 2019-2024 | Xarelto |
| Edwards Lifesciences Corporation | $37.77 | 2024 | Sapien 3 Ultra Resilia |
| Alnylam Pharmaceuticals INC. | $29.50 | 2025 | Amvuttra |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megha Prasad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.